[HTML][HTML] Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy
K Beckmann, C Reitinger, X Yan, A Carle, E Blümle… - Antibodies, 2024 - mdpi.com
The activation of CD40-mediated signaling in antigen-presenting cells is a promising
therapeutic strategy to promote immune responses against tumors. Most agonistic anti …
therapeutic strategy to promote immune responses against tumors. Most agonistic anti …